University College London Medical School Centre for Sexual Health and HIV Research
Welcome,         Profile    Billing    Logout  
 2 Trials 
3 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Pett, Sarah L
LATA, NCT05154747: Long-Acting Treatment in Adolescents

Active, not recruiting
3
476
RoW
Cabotegravir, Rilpivirine Drug Combination, CAB, RPV, TLD
University College, London, European and Developing Countries Clinical Trials Partnership (EDCTP), Janssen-Cilag Ltd., ViiV Healthcare, Department of Clinical Pharmacy, University Medical Centre St Radboud, The Netherlands., London School of Hygiene and Tropical Medicine, MRC/UVRI and LSHTM Uganda Research Unit, Africa Health Research Institute, PENTA Foundation, University of York
Hiv, HIV Infections, HIV-1-infection, Paediatric Human Immunodeficiency Virus Infection
03/25
03/26
RIO, NCT04319367 / 2019-002129-31: A Randomised Placebo Controlled Trial of ART Plus Dual Long-acting HIV-specific Broadly Neutralising Antibodies (bNAbs).

Recruiting
2
72
Europe
Investigational Medicinal Product, 10-1074-LS and 3BNC117-LS
Imperial College London, Bill and Melinda Gates Foundation, University of Oxford, Rockefeller University
HIV/AIDS and Infections
07/27
07/27
MISTRAL, NCT05421286: The Study: Gut Microbiome Correlates of Serious AIDS and Non-AIDS Events

Active, not recruiting
N/A
1000
Europe, RoW
Rigshospitalet, Denmark, IrsiCaixa, Horizon 2020 - European Commission
HIV-1-infection, Inflammation, AIDS
12/25
12/25

Download Options